Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Biopolis – The Biotechnology Cluster of Singapore

Owing to the success of Liftstream’s biotech cluster reviews and the rapid growth of its corresponding group on Linkedin. Liftstream has profiled Biopolis, the biotechnology cluster of Singapore. Singapore has established itself as a leading biotechnology cluster in not only … Continue reading

Posted in General, Pharmaceutical business | Tagged , , , | Leave a comment

Bluebird bio sings to tune of $9.3m as gene therapy shows promise

Authored by Karl Simpson Bluebird Bio is rapidly gaining a very visible profile in the area of rare diseases. Backed by a stellar line-up of investors, including Mark Levin’s Third Rock Ventures, the company have just pocketed another $9.3m from … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Shire Pharmaceuticals CEO, Angus Russell, announces departure and sucessor

Authored by Karl Simpson The last week has seen a couple of FTSE CEOs announce their departures. In this article we take a look at the record of Shire Pharmaceutical’s CEO, Angus Russell and his succession. Angus Russell is the … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

FTSE Females Falter but Diversity on course

Authored by Karl Simpson Much has been made of the diversity agenda in recent months since the Davies’ report hit the wires. It is good to see that so much is written and said about finally addressing this topic and … Continue reading

Posted in Workplace Diversity | Tagged , , , , , , , , | Leave a comment

The Market Access Challenge for Orphan Drugs

Authored by Paul Foster In 1996 I was involved in the European Launch of Rilutek, the 1st ever treatment for Amyotrophic Lateral Sclerosis (ALS) otherwise known as Motor Neurone Disease in the UK or Lou Gehrig’s Disease in the US. … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

European Society for Medical Oncology (ESMO) Congress 2012 Highlights

The European Society for Medical Oncology (ESMO) recently held its annual congress in Vienna, Austria. The congress was a flood with a variety of new and updated clinical data about a number of cancer drugs currently in development. The congress … Continue reading

Posted in General, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Rare Disease Year in Review

This year has been a tumultuous year for the rare diseases market with a number of significant news stories revolving around M&A rumours, regulatory approvals, IPO’s, investments and partnering agreements. Liftstream takes a look at these events: The rare disease … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap